C.R. Bard Becomes #89 Most Shorted S&P 500 Component, Replacing Borg Warner

The most recent short interest data has been released by the NASDAQ for the 09/15/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks »

In our new rank based on the most recent short interest data from NASDAQ, C.R. Bard, Inc. ( BCR) has taken over the position of #89 most shorted S&P 500 component, from Borg Warner Inc ( BWA) which is now in the #141 spot. The "days to cover" at 09/15/2014 was 7.11 for BCR, and 5.60 for BWA; this compares to the average across all S&P 500 components of 4.96 (down from the average back on the 08/29/2014 settlement date of 5.99). The chart below shows the movement over time of the "days to cover" values of both BCR and BWA, versus the average S&P 500 component.

Loading+chart++2014+TickerTech.com

Below is a chart showing the relative positions of BCR versus BWA over time within the 500 S&P 500 components, with #1 representing the component with the highest "days to cover" value (most heavily shorted) and #500 representing the component with the lowest "days to cover" value (least heavily shorted):

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

Deals of the Week: Waiting for Clarity

Merger Buzz Drives Akorn to Top of Health Chart in April

Deals of the Week: Reason for Optimism

Good Medicine Makes for 3 Good Charts